The flu season, already a bad one, is expected to rage into the new year, in part due to a variant flu strain the vaccine doesn’t cover.

As of mid-December, the Pennsylvania Department of Health listed 3,516 confirmed cases statewide, with 378 in Allegheny County. Confirmed cases typically represent a fraction of actual cases. Those numbers actually reflect a lot of flu activity, health officials say.

The big question is whether the United States will fare as poorly as Australia did during its winter months (June through August), with the identical flu vaccine being only 10 percent effective.

This season’s vaccine is designed to cover H1N1 and H3N2, both A strains, along with two B strains — Victoria and Yamagata, which typically come on strong later in the season. The viral villain once again is H3N2, already a troublesome strain but especially so given a variant H3N2 strain against which the vaccine is ineffective.

Advertise with us

So far this season, the U.S. Centers for Disease Control and Prevention reports that about 90 percent of flu cases nationwide have involved the expected H3N2 strain and its genetic variant, known as a “clade.” The variant represents about 20 percent of all H3N2 flu cases nationwide.

Karen Hacker, director of the Allegheny County Health Department, said flu cases countywide actually are tracking similar to last year, with no reported deaths so far.

But Richard K. Zimmerman, a flu science expert and professor of family medicine at the University of Pittsburgh School of Medicine, said the season could be similar to the 2014-2015 flu season, when the H3N2 strain predominated early in a flu season that also peaked early on Dec. 27, 2014.

Dr. Zimmerman was lead author in the CDC’s vaccine efficiency study that year, which found that “influenza vaccines offered little protection against the predominant … H3N2 virus but were effective against influenza B.”

To date this year, he said, “We know of some vaccine failures and some successes against H3N2.”

Advertise with us

Since 2004, the flu vaccine has an average effectiveness rating of 41 percent, with the low of 10 percent in 2004-2005, with the highest of 60 percent during the 2010-2011 flu season. Last year, nationwide, the vaccine was 42 percent effective.

The most recent CDC surveillance report said flu activity sharply increased in mid-December. The state Health Department says a large majority of southwestern Pennsylvania cases actually involve H1N1 infections, which are covered by the vaccine.

However, Dr. Zimmerman said that in Pittsburgh H3N2 is the dominant strain, which he described as a “bad actor.” The process of creating the vaccine against H3N2 is difficult, with that strain itself responsible for most flu deaths and the most likely to mutate genetically, all producing a double whammy.

“I expect we’ll know by the end of January” how effective the vaccine is, he said.

The brand-name anti-flu medication Tamiflu and its cheaper generic version, oseltamivir phosphate, already have been shown to be 100 percent effective against all strains in play this season. Such treatments allow the infected person to return to work one day earlier than would occur otherwise.

Advertise with us

Another factor is that predominant strains of flu, and combination of strains, often are different in Pittsburgh from four other cities used to study influenza epidemiology on a national basis, Dr. Zimmerman said.

Despite an early flu season, it remains unclear how severe the season will be, which could reflect how well the vaccine works. One thing is well-established: Influenza is unpredictable.

“I would never have guessed we would have an H3N2 year,” said Dr. Zimmerman, who thought it would be an H1N1 year. “My preseason guess was wrong. The flu keeps you humble when it comes to making predictions.”

Still, if you haven’t received a flu shot yet for this season, it’s not too late to get one. It takes 10 to 14 days to reach full protection.

David Templeton: dtempleton@post-gazette.com or 412-263-1578. Twitter: @templetoons.

This story was originally published with images that are no longer available.